Eli Lilly

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.

As of 2022, Lilly is known for its clinical depression drugs Prozac (fluoxetine) (1986), Cymbalta (duloxetine) (2004), and its antipsychotic medication Zyprexa (olanzapine) (1996), although its primary revenue drivers are the diabetes drugs Humalog (insulin lispro) (1996) and Trulicity (dulaglutide) (2014). Lilly's achievements include being the first company to mass-produce the polio vaccine developed by Jonas Salk, and insulin. It was one of the first pharmaceutical companies to produce human insulin using recombinant DNA including Humulin (insulin medication), Humalog (insulin lispro), and the first approved biosimilar insulin product in the US, Basaglar (insulin glargine).

As of 1997, it was the largest corporation and the largest charitable benefactor in Indiana. In 2019, the company was ranked 123rd on the Fortune 500. It is ranked 221st on the Forbes Global 2000 list of the largest public companies in the world and 252nd on the Forbes list of America's Best Employers. Lilly is a full member of the Pharmaceutical Research and Manufacturers of America and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Eli Lilly and Company was founded by Colonel Eli Lilly in Indianapolis, Indiana, in 1876. The company started as a drugstore and quickly grew into a major pharmaceutical company by introducing new products like Cascara Sagrada, a successful laxative. They also invested in research and development, hired scientists, and developed new drugs like Pneumonia-Specific and insulin. The company established a subsidiary in London, England, and began exporting products internationally. 

From 1901 to 1926, Eli Lilly and Company continued to expand its operations and product line, with a focus on research and development. The company introduced new products like Iletin, a standardised insulin product, and Cascara Chocolates, a popular laxative. They also established subsidiaries in Canada, Mexico, and Brazil. 

During World War I, the company produced medical supplies and drugs for the US military, and after the war, it continued to grow by acquiring other companies and expanding its research capabilities. In 1923, Eli Lilly and Company established the Eli Lilly Research Laboratories, which became a center for pharmaceutical innovation and discovery. The company had its 50th anniversary in 1926 and sales had reached $9 million. This marked a major milestone for the company and it has continued to grow and develop since then.

From 1930 to 2000, Eli Lilly and Company continued to expand its product line and research capabilities, becoming one of the largest pharmaceutical companies in the world. During this period, the company developed several important drugs, including antibiotics like penicillin and tetracycline, as well as treatments for mental health disorders and cancer. The company also expanded globally, establishing subsidiaries and research facilities in Europe, Asia, and Latin America. 

In the 1990s, Eli Lilly and Company became a leader in biotechnology, developing innovative drugs like Prozac and Humalog. The company continued to grow through mergers and acquisitions, and in 2000, it acquired the biopharmaceutical company ImClone Systems, further strengthening its position in the industry.

The company continued to focus on research and development, expanding its product line and global reach. The company developed several new drugs, including Cialis for erectile dysfunction, Forteo for osteoporosis, and Trulicity for diabetes. Eli Lilly also invested heavily in biotechnology and personalised medicine, acquiring companies like Applied Molecular Evolution and developing drugs like Verzenio for breast cancer and Olumiant for rheumatoid arthritis. 

In recent years, the company has also expanded its efforts to address public health challenges, such as developing treatments for COVID-19 and partnering with organisations to improve access to healthcare for underserved populations.

The mission of Eli Lilly and Company is to create and deliver innovative pharmaceutical products that improve the health and wellbeing of people around the world. The company is committed to conducting business ethically and responsibly, and it strives to provide high-quality medicines that are safe, effective, and affordable. 

Eli Lilly's mission also includes a focus on research and development, with the goal of discovering new treatments and cures for diseases that currently have no cure. Additionally, the company is committed to addressing important public health challenges, such as improving access to healthcare and reducing healthcare disparities.

The vision of Eli Lilly and Company is to be a leading global pharmaceutical company that delivers innovative medicines and healthcare solutions to improve patient outcomes and advance human health. The company aims to achieve this vision by focusing on research and development, investing in new technologies, and collaborating with other organizations and stakeholders in the healthcare industry. 

Eli Lilly's vision also includes a commitment to creating a diverse and inclusive workplace where employees are empowered to make a positive impact on the world. 

Fortune Magazine's "World's Most Admired Companies" list (2021, 2020, 2019, 2018, 2017) DiversityInc's "Top 50 Companies for Diversity" (2020, 2019, 2018, 2017, 2016) Human Rights Campaign Foundation's "Best Places to Work for LGBTQ Equality" (2021, 2020, 2019, 2018, 2017) Science Magazine's "Top Employers" list (2020, 2019, 2018, 2017) Forbes Magazine's "America's Best Employers for Diversity" (2021, 2020, 2019, 2018) Pharmaceutical Executive Magazine's "Pharma 50" list of top pharmaceutical companies (2020, 2019, 2018, 2017) National Association for Female Executives' "Top Companies for Executive Women" (2020, 2019, 2018, 2017) Ethisphere Institute's "World's Most Ethical Companies" list (2021, 2020, 2019, 2018, 2017) Dow Jones Sustainability Indices (DJSI) North America (2020, 2019, 2018, 2017) American Heart Association's "Fit-Friendly Worksite Platinum Award" (2017)

In the field of diabetes care, Eli Lilly offers a comprehensive portfolio of insulin products, including Humalog, Humulin, and Basaglar, which help patients manage their blood sugar levels effectively. Additionally, their GLP-1 receptor agonists, such as Trulicity and Lyxumia, offer innovative treatment options for diabetes management. To further support diabetes patients, the company provides valuable diabetes management tools and resources to enhance patient education and self-care.

Eli Lilly's commitment to oncology is evident through their development of advanced cancer treatments. They offer products like Alimta, Cyramza, and Verzenio that target different types of cancer. Furthermore, they provide supportive care products like Emend and Neulasta to help alleviate the side effects of cancer treatments and enhance patients' quality of life.

In the field of immunology, Eli Lilly focuses on developing medications for autoimmune diseases. Their drugs, such as Olumiant and Taltz, provide effective treatment options for conditions like rheumatoid arthritis and psoriasis. The company is actively engaged in clinical research programs to explore new therapies and improve patient outcomes in this field.

Eli Lilly's commitment extends to neuroscience, where they offer treatments for mental health disorders. Medications like Cymbalta, Prozac, and Zyprexa address conditions such as depression, anxiety, and bipolar disorder. Additionally, the company conducts clinical research programs aimed at finding innovative solutions for complex neurological conditions, including Alzheimer's disease.

Addressing cardiovascular health, Eli Lilly provides treatments for heart disease, such as Effient and ReoPro, which help manage and prevent cardiac conditions. They also conduct extensive research programs focused on atherosclerosis and other cardiovascular diseases, aiming to advance understanding and develop more effective therapies.

Eli Lilly's portfolio also includes men's health products, with Cialis being a well-known treatment for erectile dysfunction. Moreover, they offer medications for bone health, including Forteo, which is designed to address osteoporosis and strengthen bone density.

Recognising the importance of animal health, Eli Lilly's offerings extend to veterinary pharmaceuticals and animal health products. Notable products in this category include Trifexis and Sentinel, which help protect pets from various parasites and ensure their well-being.

In addition to their focus on medications, Eli Lilly provides clinical research services through their contract research organisation (CRO). Their CRO services support drug development and facilitate clinical trials, enabling the advancement of new therapies and treatments.

Eli Lilly offers contract manufacturing services for pharmaceuticals and biologics. This expertise allows them to collaborate with other companies to manufacture and supply high-quality medications efficiently.